Seelos Therapeutics, Inc. announced the appointment of Richard Pascoe as Chairman of the Board of Directors of Seelos to lead the ongoing strategic process and business development discussions and negotiations. Mr. Pascoe has served as member of the Seelos board since 2019.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6155 USD | -2.29% | -17.91% | -94.46% |
16/05 | Seelos Therapeutics, Inc. announced that it expects to receive $1.137029 million in funding | CI |
14/05 | Seelos Therapeutics to Implement Reverse Stock Split to Regain Bourse Compliance | MT |
1st Jan change | Capi. | |
---|---|---|
-94.46% | 16.43L | |
+16.63% | 12TCr | |
+20.11% | 12TCr | |
+21.22% | 2.66TCr | |
-23.56% | 1.99TCr | |
-17.47% | 1.63TCr | |
-45.95% | 1.55TCr | |
-18.60% | 1.55TCr | |
+62.01% | 1.48TCr | |
+2.72% | 1.37TCr |
- Stock Market
- Equities
- SEEL Stock
- News Seelos Therapeutics, Inc.
- Seelos Therapeutics, Inc. Announces Appointment of Richard Pascoe as Chairman of the Board of Directors